IP Library Patent Application 18338285
Patent Application
App. No. 18/338,285

SYSTEMS AND METHODS FOR IDENTIFYING AND TREATING PATIENTS WITH HIGH-FREQUENCY ELECTRICAL SIGNALS

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
18/338,285
Abstract

Systems and methods for identifying and treating patients with high frequency electrical signals. A representative method for identifying a patient as a candidate for pain treatment includes identifying a first sensory threshold, delivering an electrical signal to a neural population of the patient at a frequency in a frequency range of 1.5 kHz to 100 kHz and, while and/or after delivering the electrical signal to the patient, identifying a second sensory threshold of the patient. If the second sensory threshold is less than the first, the method can include identifying the patient as a candidate for receiving an electrical signal at a frequency in the foregoing range for pain treatment.

Claims (31)

1 - 28 . (canceled)

29 . A method of treating a patient having sensation loss associated with a neuropathic disease, the method comprising:

at least partially in response to the patient having the sensation loss, programming a signal generator to deliver, via at least one implanted signal delivery element, a paresthesia-free electrical signal to the patient's spinal cord to at least partially restore the lost sensation,

wherein the paresthesia-free electrical signal has a frequency of about 10 kHz, a pulse width in a pulse width range of from about 30 microseconds to about 40 microseconds, and an amplitude in an amplitude range of from 0.5 mA to 10 mA.

30 . The method of claim 29 wherein the lost sensation includes loss of response to a pin prick, pressure, heat, and/or cold.

31 . The method of claim 29 wherein the at least one implanted signal delivery element is positioned at a vertebral level of from T8 to T12.

32 . The method of claim 29 wherein the at least one signal delivery element includes at least one electrical contact implanted in the patient's epidural space.

33 . The method of claim 29 wherein programming the signal generator includes programming an implanted signal generator.

34 . The method of claim 29 wherein programming the signal generator includes programming an external signal generator.

35 . The method of claim 29 wherein the paresthesia-free electrical signal at least partially restores the lost sensation by increasing transmission of neural activity induced in response to a sensory input.

36 . The method of claim 29 wherein the paresthesia-free electrical signal at least partially restores the lost sensation by restoring transmission of naturally occurring neural activity.

37 . A method of treating a patient having sensation loss associated with a neuropathic disease, the method comprising:

at least partially in response to the patient having the sensation loss, programming a signal generator to deliver, via at least one implanted signal delivery element, a paresthesia-free electrical signal to the patient's spinal cord,

wherein the paresthesia-free electrical signal has a frequency in a frequency range of from about 5 kHz to about 15 kHz, and

wherein the paresthesia-free electrical signal at least partially restores the lost sensation.

38 . The method of claim 37 wherein the paresthesia-free electrical signal has a pulse width in a pulse width range of from about 20 microseconds to about 100 microseconds.

39 . The method of claim 37 wherein the paresthesia-free electrical signal has an amplitude in an amplitude range of from 0.5 mA to 10 mA.

40 . The method of claim 37 wherein programming the signal generator includes programming an implantable signal generator.

41 . The method of claim 37 wherein the paresthesia-free electrical signal at least partially restores the lost sensation by increasing transmission of neural activity induced in response to a sensory input.

42 . The method of claim 37 wherein the paresthesia-free electrical signal at least partially restores the lost sensation by restoring transmission of naturally occurring neural activity.

43 . The method of claim 37 wherein the lost sensation includes loss of response to a pin prick, pressure, heat, and/or cold.

44 . The method of claim 37 wherein the at least one implanted signal delivery element is positioned at a vertebral level of from T8 to T12.

45 . A method of treating a patient having sensation loss associated with a neuropathic disease, the method comprising:

at least partially in response to the patient having the sensation loss, programming a signal generator to deliver, via at least one implanted signal delivery element, a paresthesia-free electrical signal to the patient's spinal cord,

wherein the paresthesia-free electrical signal has a frequency in a frequency range of from about 1.5 kHz to about 100 kHz, and

wherein the paresthesia-free electrical signal at least partially restores the lost sensation.

46 . The method of claim 45 wherein the frequency range is from about 1.5 kHz to about 50 kHz, and wherein the paresthesia-free electrical signal has a pulse width in a pulse width range of from about 10 microseconds to about 133 microseconds, and an amplitude in an amplitude range of from 0.5 mA to 10 mA.

47 . The method of claim 45 wherein the paresthesia-free electrical signal at least partially restores the lost sensation by increasing transmission of neural activity induced in response to a sensory input.

48 . The method of claim 45 wherein the paresthesia-free electrical signal at least partially restores the lost sensation by restoring transmission of naturally occurring neural activity.

49 . The method of claim 45 wherein the lost sensation includes loss of response to a pin prick, pressure, heat, and/or cold.

50 . The method of claim 45 wherein the at least one implanted signal delivery element is positioned at a vertebral level of from T8 to T12.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 20, 2023
From: LEE, DONGCHUL
To: NEVRO CORP.
Reel/Frame 064003/0145 →